Coverage
-
May 22, 2017
A New Jersey federal judge has ordered Roxane Laboratories Inc. to pay $2 million in legal fees in a patent infringement claim against two generic-drug makers over a kidney medication, a ruling that follows the jurist's previous declaration that the case was "exceptional" for its lack of a legal basis.
2 other articles on this case.
View all »